查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
甲真菌病全球市場規模調查和預測按類型（遠端甲真菌病,淺表白色甲真菌病,近端甲真菌病,其他）,治療方法（口服,甲真菌病,局部,其他）區域分析2022-2029
市場調查報告書
商品編碼
1251571

甲真菌病全球市場規模調查和預測按類型（遠端甲真菌病,淺表白色甲真菌病,近端甲真菌病,其他）,治療方法（口服,甲真菌病,局部,其他）區域分析2022-2029

Global Onychomycosis Market Size study & Forecast, by Type (Distal Subungual Onychomycosis, White Superficial Onychomycosis, Proximal Subungual Onychomycosis, Other Types) by Treatment (Oral, Topical, Others) and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

2021 年全球甲真菌病市場價值約為 33 億美元，預計在 2022-2029 年預測期內將以超過 4.56% 的健康增長率增長。

甲癬是一種指甲真菌感染。 它可能由皮膚癬菌或非皮膚癬菌黴菌引起。 症狀始於指甲及其周圍皮膚的物理變化。 指甲和組織經常變白或變黃，指甲可能變厚,變脆,變脆。 如果不加以控制，這些疾病的身體問題可能會變得更糟，並導致疼痛和炎症。 甲真菌病感染高發,新藥研發投資增加,人口老齡化加劇,慢性病發病率上升以及抗真菌藥物容易獲得等因素推動了市場增長。

根據美國國家醫學圖書館的數據，甲癬影響了全世界 10% 的人。 主要傳染性真菌推測為紅色毛癬菌。 此外，真菌和皮膚癬菌是非皮膚真菌，也是引起甲癬的原因。 在 98% 的感染中發現了紅色毛癬菌。 此外，2019 年製藥行業的研發支出達到 830 億美元。 2010 年至 2019 年，美國食品藥品監督管理局 (FDA) 平均批准了 38 種新藥，比過去十年的年平均水平高出 60%。 甲癬感染的增加,研發投入的增加和新藥開發是推動市場擴張的主要因素。 此外，老齡化社會,慢性病增加,抗真菌藥物的可及性也是支撐市場擴張的重要因素。 此外，對甲癬治療的認識不斷提高和糖尿病患者人數的增加是在預測期內創造重要市場機會的因素。 然而，對甲癬感染的認識不足阻礙了整個 2022-2029 年預測期內的市場增長。

全球甲癬市場研究考慮的主要區域是亞太地區,北美,歐洲,拉丁美洲和世界其他地區。 由於甲癬感染率上升,醫療保健支出增加,對甲癬藥物的認識提高以及政府加大研發力度，北美在收入方面佔據了市場主導地位。我來了。 由於甲癬發病率較高,老年人口增加,城市化進程加快以及大公司對研發投資的關注等因素，預計亞太地區在預測期內將以最高複合年增長率增長。

內容

第 1 章執行摘要

  • 市場概況
  • 2019-2029 年各細分市場的全球市場估計和預測
    • 2019-2029 年按地區劃分的甲癬市場
    • 2019-2029 年按類型劃分的甲癬市場
    • 2019-2029 年甲癬市場，按治療方式
  • 主要趨勢
  • 調查方法
  • 調查先決條件

第 2 章甲癬全球市場定義和範圍

  • 調查目的
  • 市場定義和範圍
    • 調查範圍
    • 工業發展
  • 本次調查涵蓋的年份
  • 貨幣兌換率

第 3 章甲真菌病的全球市場動態

  • 甲癬市場影響分析 (2019-2029)
    • 市場驅動因素
      • 甲真菌感染的高流行率
      • 加大對新藥研發的投入
    • 市場挑戰
      • 缺乏對甲癬感染的認識
    • 市場機會
      • 提高對甲癬治療的認識
      • 糖尿病患者增加

第 4 章甲癬全球市場行業分析

  • 波特 5 力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係
  • 波特 5 力模型的未來方法 (2019-2029)
  • 害蟲分析
    • 政治
    • 經濟的
    • 社交
    • 技術
  • 投資招聘模式
  • 分析師的建議和結論
  • 最佳投資機會
  • 關鍵成功策略

第 5 章風險評估 COVID-19 影響

  • 評估 COVID-19 對行業的總體影響
  • COVID-19 之前和 COVID-19 之後的市場情景

第 6 章全球甲癬市場：按類型

  • 市場概況
  • 全球甲癬市場：按類型,按性能 - 潛力分析
  • 2019-2029 年按類型分列的甲癬全球市場估計和預測
  • 甲癬市場,細分市場分析
    • 遠端甲下甲癬
    • 淺表白色甲癬
    • 近端甲下甲癬
    • 其他類型

第 7 章全球甲癬市場，按治療

  • 市場概況
  • 甲癬全球市場：按治療,按表現 - 潛力分析
  • 2019-2029 年甲癬全球市場估計和治療預測
  • 甲癬市場,細分市場分析
    • 口語
    • 本地
    • 其他

第 8 章全球甲癬市場：區域分析

  • 甲癬市場，按地區劃分的市場概況
  • 北美
    • 美國
      • 按類型估算和預測，2019-2029 年
      • 2019-2029 年各治療方法的估計和預測
    • 加拿大
  • 歐洲甲癬市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲
  • 亞太地區甲癬市場概況
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲甲癬市場概況
    • 巴西
    • 墨西哥
  • 世界其他地方

第 9 章衝突信息

  • 頂級市場策略
  • 公司簡介
    • Bausch Health Companies Inc.
      • 關鍵信息
      • 概覽
      • 財務（僅當數據可用時）
      • 產品概述
      • 近期趨勢
    • Gsk Plc
    • Abbott
    • Pfizer Inc.
    • Bayer Ag
    • Teva Pharmaceutical Industries, Ltd.
    • Cipla Inc.
    • Novartis Ag
    • Sun Pharmaceutical Industries Ltd.
    • Merck & Co., Inc.

第 10 章研究過程

  • 研究過程
    • 數據挖掘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 調查的特點
  • 調查先決條件

Global Onychomycosis Market is valued at approximately USD 3.3 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 4.56% over the forecast period 2022-2029. Onychomycosis is a fungal infection of the nails, and can also be referred to as dermatophytic onychomycosis. This can be a cause of dermatophytes and nondermatophytic molds. The symptoms begin with physical alterations to the nail and surrounding skin. The nail and tissue frequently turn white or yellow, and the nails might thicken and become brittle, making them more likely to break. Physical problems in this condition might deteriorate noticeably and cause pain and inflammation if not managed. The high prevalence of Onychomycosis infections, increasing investments in the R&D of novel drugs, increasing ageing population, rising incidence of chronic diseases, and easy accessibility of antifungal drugs are the factors driving the growth of the market.

According to the National Library of Medicine, there is 10% of the Onychomycosis infected population across the globe. Trichophyton rubrum was estimated to be the main infecting organism. Nondermatophyte mould and dermatophytes are the other causes of Onychomycosis infections. T. rubrum organisms were found in 98% of the infections. Additionally, The R&D expenditure in the pharmaceutical industry amounted to 83 billion dollars in 2019. Between 2010 and 2019, the Food and Drug Administration (FDA) approved 38 new medications on average, which is 60% more than it did on an annual average over the preceding ten years. Increasing Onychomycosis infections and increasing R&D investments and development of new drugs are the major factors driving the market growth. Other important components driving market increase are the increasing ageing population, rising incidence of chronic diseases, and easy accessibility of antifungal drugs. Furthermore, rising awareness about the treatment of Onychomycosis and the growing Diabetic Population are the factors creating major market opportunities in the forecast period. However, the lack of awareness of onychomycosis infections stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Onychomycosis Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the rising prevalence of Onychomycosis infections, increasing healthcare expenditures, increase in the awareness of Onychomycosis drugs, and increasing government initiatives in R&D. Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as high incidence of Onychomycosis infections, a growing geriatric population, increasing urbanization and focus of key players on investing in R&D.

Major market players included in this report are:

  • Bausch Health Companies Inc.
  • Gsk Plc
  • Abbott
  • Pfizer Inc.
  • Bayer Ag
  • Teva Pharmaceutical Industries, Ltd.
  • Cipla Inc.
  • Novartis Ag
  • Sun Pharmaceutical Industries Ltd.
  • Merck & Co., Inc.

Recent Developments in the Market:

  • In March 2021, The Tianjin Institute of Pharmaceutical Research and HUYABIO International joint venture, submitted a new drug application efinaconazole, as Jublia™ for the treatment of onychomycosis.
  • In July 2021, Kaken Pharmaceutical (KKPCF) and Almirall S.A., a global biopharmaceutical company specializing in skin health, announced that they have signed a license and distribution agreement under which Kaken Pharmaceutical gives Almirall the exclusive right to develop and market the topical formulation of efinaconazole in Europe.

Global Onychomycosis Market Report Scope:

  • Historical Data 2019-2020-2021
  • Base Year for Estimation 2021
  • Forecast period 2022-2029
  • Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered Type, Treatment, Region
  • Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Distal Subungual Onychomycosis
  • White Superficial Onychomycosis
  • Proximal Subungual Onychomycosis
  • Other Types

By Treatment:

  • Oral
  • Topical
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Onychomycosis Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Onychomycosis Market, by Type, 2019-2029 (USD Billion)
    • 1.2.3. Onychomycosis Market, by Treatment, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Onychomycosis Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Onychomycosis Market Dynamics

  • 3.1. Onychomycosis Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. High prevalence of Onychomycosis infections
      • 3.1.1.2. Increasing investments in the R&D of novel drugs
    • 3.1.2. Market Challenges
      • 3.1.2.1. Lack of awareness of onychomycosis infections
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising awareness about the treatment of Onychomycosis
      • 3.1.3.2. Growing Diabetic Population

Chapter 4. Global Onychomycosis Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Onychomycosis Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Onychomycosis Market by Type, Performance - Potential Analysis
  • 6.3. Global Onychomycosis Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
  • 6.4. Onychomycosis Market, Sub Segment Analysis
    • 6.4.1. Distal Subungual Onychomycosis
    • 6.4.2. White Superficial Onychomycosis
    • 6.4.3. Proximal Subungual Onychomycosis
    • 6.4.4. Other Types

Chapter 7. Global Onychomycosis Market, by Treatment

  • 7.1. Market Snapshot
  • 7.2. Global Onychomycosis Market by Treatment, Performance - Potential Analysis
  • 7.3. Global Onychomycosis Market Estimates & Forecasts by Treatment 2019-2029 (USD Billion)
  • 7.4. Onychomycosis Market, Sub Segment Analysis
    • 7.4.1. Oral
    • 7.4.2. Topical
    • 7.4.3. Others

Chapter 8. Global Onychomycosis Market, Regional Analysis

  • 8.1. Onychomycosis Market, Regional Market Snapshot
  • 8.2. North America Onychomycosis Market
    • 8.2.1. U.S. Onychomycosis Market
      • 8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Treatment breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Onychomycosis Market
  • 8.3. Europe Onychomycosis Market Snapshot
    • 8.3.1. U.K. Onychomycosis Market
    • 8.3.2. Germany Onychomycosis Market
    • 8.3.3. France Onychomycosis Market
    • 8.3.4. Spain Onychomycosis Market
    • 8.3.5. Italy Onychomycosis Market
    • 8.3.6. Rest of Europe Onychomycosis Market
  • 8.4. Asia-Pacific Onychomycosis Market Snapshot
    • 8.4.1. China Onychomycosis Market
    • 8.4.2. India Onychomycosis Market
    • 8.4.3. Japan Onychomycosis Market
    • 8.4.4. Australia Onychomycosis Market
    • 8.4.5. South Korea Onychomycosis Market
    • 8.4.6. Rest of Asia Pacific Onychomycosis Market
  • 8.5. Latin America Onychomycosis Market Snapshot
    • 8.5.1. Brazil Onychomycosis Market
    • 8.5.2. Mexico Onychomycosis Market
  • 8.6. Rest of The World Onychomycosis Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Bausch Health Companies Inc.
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Gsk Plc
    • 9.2.3. Abbott
    • 9.2.4. Pfizer Inc.
    • 9.2.5. Bayer Ag
    • 9.2.6. Teva Pharmaceutical Industries, Ltd.
    • 9.2.7. Cipla Inc.
    • 9.2.8. Novartis Ag
    • 9.2.9. Sun Pharmaceutical Industries Ltd.
    • 9.2.10. Merck & Co., Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Onychomycosis Market, report scope
  • TABLE 2. Global Onychomycosis Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Onychomycosis Market estimates & forecasts by Type 2019-2029 (USD Billion)
  • TABLE 4. Global Onychomycosis Market estimates & forecasts by Treatment 2019-2029 (USD Billion)
  • TABLE 5. Global Onychomycosis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Onychomycosis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Onychomycosis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Onychomycosis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Onychomycosis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Onychomycosis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Onychomycosis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Onychomycosis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Onychomycosis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Onychomycosis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Onychomycosis Market
  • TABLE 70. List of primary sources, used in the study of global Onychomycosis Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Onychomycosis Market, research methodology
  • FIG 2. Global Onychomycosis Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Onychomycosis Market, key trends 2021
  • FIG 5. Global Onychomycosis Market, growth prospects 2022-2029
  • FIG 6. Global Onychomycosis Market, porters 5 force model
  • FIG 7. Global Onychomycosis Market, pest analysis
  • FIG 8. Global Onychomycosis Market, value chain analysis
  • FIG 9. Global Onychomycosis Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Onychomycosis Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Onychomycosis Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Onychomycosis Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Onychomycosis Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Onychomycosis Market, regional snapshot 2019 & 2029
  • FIG 15. North America Onychomycosis Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Onychomycosis Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Onychomycosis Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Onychomycosis Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Onychomycosis Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable